Looking for answers?

PY2027 ALS Special Booster Programme

Amway MSB Helpdesk
Amway MSB Helpdesk
PROMOTION

PY2027 ALS Special
Booster Programme

Additional support for 2nd Timer and above Leaders building towards Amway Leadership Seminar 2027 in Madrid.

ACHIEVE
13,500
RUBY PV
Each month from Nov 2026-Feb 2027
RECEIVE
700
ALS BONUS POINTS
Additional support towards your ALS qualification target
WHO IS ELIGIBLE?
2nd Timer and above in PY2027
PROGRAMME PERIOD
November 2026-February 2027
Important: The 700 ALS Bonus Points are additional support towards ALS qualification. Leaders must still generate the required sales and fulfil the applicable ALS qualification requirements.

Participation Tiers

2nd Timer
  • Achieve 13,500 PV between Nov 2026-Feb 2027 and 12,500 PV for the remaining 8 months.
  • Achieve 13,500 Ruby PV between Nov 2026-Feb 2027.
  • Maintain one 21% group for 6 months.
Target: 13,000
Illustrative total ALS amount: 13,161
3rd Timer
  • Achieve 13,500 PV from Nov 2026-Feb 2027 and 12,500 PV for the remaining 8 months.
  • Achieve 13,500 Ruby PV between Nov 2026-Feb 2027.
  • Maintain one 21% group for 12 months.
Target: 16,000
Illustrative total ALS amount: 16,536
4th Timer
  • Achieve 13,500 PV from Nov 2026-Feb 2027 and 12,500 PV for the remaining 8 months.
  • Achieve 13,500 Ruby PV between Nov 2026-Feb 2027.
  • Maintain one 21% group for 7 months and two 21% groups for 5 months.
Target: 19,000
Illustrative total ALS amount: 19,349

Illustrative ALS Amount Breakdown

Tier Total ALS 1 Total ALS 2 ALS Bonus Points Special Booster Total
2nd Timer 8,085 3,376 1,000 700 13,161
3rd Timer 8,085 6,751 1,000 700 16,536
4th Timer 8,085 9,564 1,000 700 19,349

Formula reference: Total ALS 1 = PV x 0.25 x PB %. Total ALS 2 = 6% LB (RM) x 0.75 x PVBV Ratio.

Disclaimer: The amounts above are for illustrative purposes only. The actual amount you earn depends on your personal and group volume.

Was this article helpful?

0 out of 0 found this helpful

Tell us how it could be more helpful.

Share your feedback.